A peek behind the paper – Kate Lines on epigenetic dysregulation in pituitary tumors

Photo credit: NIH NCI Visuals Online Take a look behind the scenes of a recent International Journal of Endocrine Oncology article, entitled ‘Epigenetic dysregulation in pituitary tumors’, as we ask lead author Kate Lines from the University of Oxford (UK) about how research into epigenetics could translate into clinical benefit for patients with pituitary cancers and other tumor types, as well as what the future might hold for tumor epigenetics.Could you introduce yourself and explain what began your interest in researching the epigenetic mechanisms behind tumor development? I am a Scientist at the University of Oxford working on understanding the...